Alphabet’s AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis
Alphabet’s Isomorphic, an AI-driven drug discovery startup, has scored two major deals from pharmaceutical giants Eli Lilly and Novartis, ringing in at nearly $3 billion combined. These deals will notably bolster Google DeepMind’s AlphaFold AI technology, known for predicting protein
The post Alphabet’s AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis first appeared on TechStartups.
Alphabet’s Isomorphic, an AI-driven drug discovery startup, has scored two major deals from pharmaceutical giants Eli Lilly and Novartis, ringing in at nearly $3 billion combined. These deals will notably bolster Google DeepMind’s AlphaFold AI technology, known for predicting protein […]
The post Alphabet’s AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis first appeared on TechStartups.